Type 1 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 1 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-03-12FDA Approved: AFREZZA — Supplemental Application (Mannkind Corporation)
FDA approves a supplemental application for AFREZZA (insulin human) from MannKind Corporation. The approval relates to labeling/indication e…
-
FDA approval · 2015-03-03FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humulin N (insulin human) submitted by Eli Lilly and Company.
-
FDA approval · 2015-02-25FDA Approved: TOUJEO — Original Application (Sanofi-Aventis U.S. LLC)
FDA approved Toujeo (insulin glargine) through its original application, establishing a concentrated long-acting insulin product for glycemi…
-
FDA approval · 2015-02-25FDA Approved: LANTUS SOLOSTAR — Supplemental Application (sanofi-aventis U.S. LLC)
FDA approved a supplemental application for Lantus SoloStar (insulin glargine) from sanofi-aventis U.S. LLC. The insulin product is used to …
-
FDA approval · 2015-02-25FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for insulin lispro from Eli Lilly, updating approval details for this product.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-02-25FDA Approved: SYMLINPEN — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for SymlinPen (pramlintide acetate) by AstraZeneca Pharmaceuticals LP.
-
FDA approval · 2015-02-25FDA Approved: NOVOLIN N — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for NOVOLIN N (human insulin) from Novo Nordisk.
-
FDA approval · 2015-02-25FDA Approved: NOVOLOG — Supplemental Application (Novo Nordisk)
The FDA has approved a supplemental application for NOVOLOG (insulin aspart) from Novo Nordisk. The approval relates to changes to the produ…
-
FDA approval · 2015-02-25FDA Approved: APIDRA — Supplemental Application (sanofi-aventis U.S. LLC)
FDA approved a supplemental application for APIDRA (insulin glulisine) submitted by Sanofi-Aventis U.S. LLC.
-
FDA approval · 2015-02-25FDA Approved: HUMALOG MIX75/25 — Supplemental Application (Eli Lilly and Company)
FDA approves a supplemental application for Humalog Mix75/25 (insulin lispro) from Eli Lilly and Company.
-
FDA approval · 2015-02-25FDA Approved: HUMALOG MIX50/50 KWIKPEN — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humalog Mix50/50 KwikPen (insulin lispro) from Eli Lilly, expanding the approved formulation…
-
FDA approval · 2015-02-25FDA Approved: HUMULIN R — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humulin R (insulin human) from Eli Lilly and Company.
-
FDA approval · 2015-01-26FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for insulin lispro from Eli Lilly, including the associated diluent as part of the approved product.
-
FDA approval · 2015-01-23FDA Approved: NOVOLOG — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for NovoLog (insulin aspart) from Novo Nordisk, expanding the product’s regulatory authorization…
-
FDA approval · 2015-01-23FDA Approved: LEVEMIR — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for LEVEMIR (insulin detemir) from Novo Nordisk, resulting in changes to the product labeling as…
-
FDA approval · 2015-01-14FDA Approved: NOVOLOG — Supplemental Application (Novo Nordisk)
FDA approved NovoLog (insulin aspart) supplemental application submitted by Novo Nordisk. This action represents a supplemental approval, li…
-
FDA approval · 2015-01-12FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMULIN N (insulin human) from Eli Lilly and Company. This action confirms approval of a supplem…
-
FDA approval · 2014-11-11FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for insulin lispro submitted by Eli Lilly and Company.
-
FDA approval · 2014-10-30FDA Approved: HUMULIN R — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humulin R (insulin human) from Eli Lilly and Company.
-
FDA approval · 2014-09-30FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humulin N (insulin human) from Eli Lilly and Company.
-
FDA approval · 2014-09-12FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humulin N (insulin human) submitted by Eli Lilly and Company.
-
FDA approval · 2014-09-12FDA Approved: HUMALOG MIX50/50 KWIKPEN — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMALOG MIX50/50 KWIKPEN (insulin lispro) from Eli Lilly and Company.
-
FDA approval · 2014-09-12FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for insulin lispro from Eli Lilly and Company, with the submission involving a diluent component.
-
FDA approval · 2014-09-05FDA Approved: LANTUS SOLOSTAR — Supplemental Application (sanofi-aventis U.S. LLC)
FDA approves a supplemental application for LANTUS SOLOSTAR (insulin glargine) by Sanofi-U.S. LLC.
-
FDA approval · 2014-09-04FDA Approved: INSULIN ASPART PROTAMINE AND INSULIN ASPART MIX 70/30 — Supplemental Application (Novo Nordisk Pharma, Inc.)
FDA approved a supplemental application for INSULIN ASPART PROTAMINE AND INSULIN ASPART MIX 70/30 (insulin aspart mix 70/30) from Novo Nordi…